health · 14 min read

Insomnia Self-Assessment: Symptoms, Severity & What to Do

Insomnia self-assessment: score ISI symptoms, understand severity, and learn why insomnia self-assessment points to CBT-I over sleeping pills

Published 5/19/2026

Ad slot · Sponsored · (Set VITE_ADSENSE_CLIENT to enable AdSense)

Insomnia is the most prevalent sleep disorder in the world. A 2025 meta-analysis of 47 population studies published in the Journal of Sleep Research (van Straten et al.) established a pooled prevalence of 12.4% using interview-based DSM criteria and 16.3% using validated self-report tools — meaning somewhere between one in six and one in eight adults meets the clinical criteria for insomnia disorder. Yet the vast majority never receive an accurate assessment, appropriate treatment, or even a correct understanding of what is actually happening to their sleep.

The problem is compounded by widespread confusion. Many people use "insomnia" loosely to mean any bad night. Others assume it means total inability to sleep. Neither is accurate. Clinically, insomnia disorder is a specific, precisely defined condition — distinct from sleep debt, distinct from poor sleep hygiene, distinct from the temporary sleep difficulties of a stressful week — and the distinction matters enormously because insomnia and sleep debt require different interventions.

An insomnia self-assessment is the first step toward clarity. It allows you to score your symptoms against validated clinical criteria, understand whether what you are experiencing is likely insomnia disorder or a different sleep problem, gauge severity, and identify the right pathway forward — whether that is behavioural treatment, medical evaluation, or simply improving sleep hygiene and reducing sleep debt.

This article explains the clinical definition of insomnia disorder, walks you through the most validated self-assessment tool (the Insomnia Severity Index), explains how to interpret your score, covers the full range of insomnia causes, and outlines the treatment options backed by the strongest evidence.

Insomnia Self-Assessment: What Your Symptoms Are Telling You

What Is Insomnia Disorder — And What It Is Not

Insomnia is not simply "having trouble sleeping." The DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition) defines insomnia disorder as a specific clinical condition requiring all of the following criteria to be present:

Criterion A — Sleep complaint: Difficulty with one or more of:

Falling asleep (sleep onset insomnia)
Staying asleep — waking during the night and difficulty returning to sleep (sleep maintenance insomnia)
Early morning awakening — waking significantly earlier than desired and being unable to return to sleep

Criterion B — Daytime consequences: The sleep difficulty causes clinically significant distress or impairment in one or more areas:

Fatigue or low energy
Attention, concentration, or memory impairment
Mood disturbance (irritability, dysphoria, anxiety)
Behavioural problems (hyperactivity, impulsivity, aggression — particularly in children)
Reduced motivation, energy, or initiative
Errors or accidents at work or while driving
Concerns or dissatisfaction about sleep

Criterion C — Frequency: Occurs at least three nights per week

Criterion D — Duration: Has been present for at least three months (chronic insomnia)

Criterion E — Opportunity: The sleep difficulty occurs despite adequate opportunity and circumstances for sleep

Criterion F — Not better explained by: Another sleep disorder (e.g. narcolepsy, sleep apnea, circadian rhythm disorder), a substance or medication, or a co-occurring mental disorder

The last criterion is critically important: insomnia is a diagnosis of inclusion as well as exclusion. It requires genuine difficulty with sleep initiation, maintenance, or early awakening — not just feeling tired from insufficient sleep, not just sleeping at the wrong time due to a circadian disorder, and not just having fragmented sleep because of an underlying disorder like sleep apnea.

Insomnia vs sleep debt: The most common clinical confusion is between insomnia disorder and sleep debt. A person with sleep debt sleeps less than their need — but typically falls asleep readily, sleeps through the night without significant fragmentation, and would sleep longer if given the opportunity (the alarm-free test). A person with insomnia disorder wants to sleep, has adequate opportunity to sleep, but cannot — due to difficulty initiating or maintaining sleep. Sleep debt is a quantity problem; insomnia is a quality and process problem. Both can coexist, and both should be assessed separately. Use the Sleep Debt Calculator for your debt assessment alongside the Insomnia Self-Assessment for insomnia screening.

The Three Types of Insomnia

Understanding which type of insomnia you are experiencing is clinically important because they reflect different underlying mechanisms and respond to slightly different treatment emphases within the CBT-I framework.

Sleep onset insomnia (difficulty falling asleep)

Characterised by a prolonged sleep onset latency — typically defined as more than 30 minutes to fall asleep on three or more nights per week. Most commonly associated with hyperarousal at bedtime: racing thoughts, anxiety about sleep, an activated nervous system that will not downregulate, or circadian misalignment (being asked to sleep at a time that does not match your biological clock).

Sleep onset insomnia is the most common type in younger adults and those with anxiety disorders. It responds particularly well to the sleep restriction and stimulus control components of CBT-I, which reduce the hyperarousal cycle that perpetuates it.

Sleep maintenance insomnia (waking during the night)

Characterised by one or more awakenings per night lasting 30 minutes or more, with difficulty returning to sleep. This is the most common type of insomnia in older adults, where declining slow-wave sleep produces lighter, more easily disrupted sleep architecture. It is also common in women during perimenopause and menopause, where vasomotor symptoms directly fragment sleep.

Sleep maintenance insomnia is often associated with anxiety during nocturnal awakenings — the so-called "2 AM mind" when the absence of daytime distractions allows worries to amplify. It also occurs in the context of undiagnosed sleep apnea, which causes repeated micro-arousals that eventually produce full awakenings.

Early morning awakening insomnia

Characterised by waking significantly earlier than desired — typically one to two hours before the intended wake time — without being able to return to sleep. This type is most strongly associated with depression (early morning awakening is one of the classic neurovegetative symptoms of major depressive disorder) and with the circadian clock advancement of aging.

The Insomnia Severity Index (ISI): The Gold-Standard Self-Assessment Tool

The Insomnia Severity Index (ISI) is the most widely validated, most clinically used self-report insomnia assessment tool in the world. It was developed by Charles Morin (Université Laval) and has been validated across hundreds of studies in dozens of languages. It is used as both a screening tool and an outcome measure in clinical trials of insomnia treatment.

The ISI consists of seven questions, each rated on a 5-point scale (0–4). The total score out of 28 indicates insomnia severity.

The seven ISI questions

For each of the following, rate the severity of your problem over the past two weeks on a scale from 0 (none) to 4 (very severe):

#	Question	Score (0–4)
1	Severity of sleep onset difficulty (difficulty falling asleep)
2	Severity of sleep maintenance difficulty (difficulty staying asleep)
3	Severity of early morning awakening problem
4	How satisfied/dissatisfied are you with your current sleep pattern? (0 = very satisfied, 4 = very dissatisfied)
5	How noticeable to others do you think your sleep problem is in terms of impairing the quality of your life? (0 = not noticeable, 4 = very noticeable)
6	How worried/distressed are you about your current sleep problem? (0 = not worried, 4 = very worried)
7	To what extent do you consider your sleep problem to interfere with daily functioning (e.g. daytime fatigue, mood, ability to function at work/daily chores, concentration, memory, mood)? (0 = not at all interfering, 4 = very much interfering)

Add your scores for questions 1–7 for your total ISI score.

Interpreting your ISI score

Total score	Clinical interpretation	Recommended action
0–7	No clinically significant insomnia	Monitor; review sleep hygiene
8–14	Sub-threshold insomnia	Sleep hygiene improvement; consider self-help CBT-I if persistent
15–21	Moderate clinical insomnia	CBT-I — either therapist-guided or validated digital program
22–28	Severe clinical insomnia	Urgent CBT-I; physician evaluation recommended

A score of 8 or above on the ISI is the standard clinical threshold for identifying insomnia that warrants intervention. A score of 15 or above indicates moderate-to-severe clinical insomnia that typically requires a structured treatment program.

The RAND Corporation's societal and economic burden analysis used an ISI threshold of 8 to define subclinical insomnia and 15 for clinical insomnia — the same thresholds used across most large epidemiological research.

Use the Insomnia Self-Assessment tool for a guided, scored version of this assessment.

What Causes Insomnia Disorder?

Understanding insomnia causes is essential for choosing the right treatment, because the same symptom — difficulty sleeping — can have multiple different drivers requiring different interventions.

The 3P model: the clinical framework for insomnia causes

The most clinically accepted model for understanding insomnia causation is the 3P model (Spielman's predisposing-precipitating-perpetuating model):

Predisposing factors — the underlying vulnerabilities that make a person more susceptible to insomnia:

Genetic predisposition: twin studies show significant heritability of insomnia (~40–50%)
Trait anxiety or neuroticism: people with higher baseline anxiety are more likely to develop insomnia following stressful events
Biological hyperarousal: elevated physiological arousal (higher body temperature at night, elevated cortisol, faster resting heart rate) is a documented biological feature of insomnia patients
Female sex: women have approximately 1.5× higher insomnia prevalence than men across all age groups

Precipitating factors — the events or circumstances that trigger an insomnia episode:

Acute stress (work pressure, relationship crisis, bereavement, health diagnosis)
Illness or pain causing nighttime discomfort
Environmental change (new home, travel, new sleeping arrangement)
Medication changes (stimulant medications, steroids, antidepressant initiation)
Life transitions (parenthood, retirement, shift work changes)
Jet lag or circadian disruption

Perpetuating factors — the behaviours and thoughts that maintain insomnia long after the precipitating cause has resolved. These are the most clinically important factors because they explain why insomnia often persists for months or years after the original trigger has passed:

Excessive time in bed: Spending more time in bed than you actually sleep, trying to compensate for poor sleep. This reduces sleep pressure and perpetuates the pattern.
Irregular sleep schedules: Variable bedtimes and wake times disrupt circadian entrainment and make consistent sleep harder.
Negative sleep associations: The bed and bedroom becoming associated with wakefulness, frustration, and anxiety rather than sleep — through classical conditioning.
Sleep effort: The harder you try to sleep, the more aroused you become. Hyper-monitoring of sleep, clock-watching, and catastrophising about the consequences of poor sleep all increase arousal and perpetuate insomnia.
Compensatory behaviours: Napping to make up for lost night sleep, caffeine to overcome daytime fatigue, and alcohol to induce sleep — all of which worsen nighttime sleep quality.

Understanding which perpetuating factors are active in your case is the key to effective CBT-I treatment — because CBT-I specifically targets these behaviours and thoughts rather than treating symptoms pharmacologically.

Medical and psychiatric causes

Insomnia frequently co-occurs with or is secondary to medical and psychiatric conditions:

Pain conditions: Chronic pain — from arthritis, back problems, fibromyalgia, neuropathy — produces nighttime discomfort that directly fragments sleep and can drive all three types of insomnia. Pain-related insomnia requires both pain management and insomnia treatment.

Mental health disorders: Insomnia is present in approximately 90% of major depressive disorder cases, 70% of generalised anxiety disorder cases, and the majority of PTSD cases. The 2024 ScienceDirect systematic review confirmed CBT-I's efficacy in comorbid insomnia and depression, with both insomnia and depression improving concurrently. Treating insomnia in the context of depression significantly improves depression outcomes — making insomnia treatment a key part of mental health care, not merely a secondary concern.

Obstructive sleep apnea: As discussed in our Sleep Apnea Risk Screener article, OSA causes sleep fragmentation that can present as sleep maintenance insomnia. In people with both conditions — "comorbid insomnia and sleep apnea" (COMISA) — treating only one condition produces suboptimal outcomes; both require concurrent management.

Restless leg syndrome (RLS): The uncomfortable urge to move the legs during rest, particularly in the evening and when lying down, is one of the most common causes of sleep onset insomnia and is often underdiagnosed. RLS affects approximately 10% of adults and has a strong genetic component.

Thyroid disorders: Both hypothyroidism and hyperthyroidism can cause insomnia — hypothyroidism through daytime fatigue that disrupts sleep pressure, hyperthyroidism through physiological hyperarousal.

Medications: Many commonly prescribed medications cause or worsen insomnia as a side effect: some antidepressants (particularly SSRIs and SNRIs), beta blockers, corticosteroids, stimulant ADHD medications, decongestants, and some blood pressure medications. Review any recent medication changes if insomnia onset correlates with a new prescription.

How Insomnia Perpetuates and Amplifies Sleep Debt

Insomnia and sleep debt interact in a particularly damaging way: insomnia disorder generates sleep debt as a direct consequence of chronically insufficient or non-restorative sleep, while simultaneously preventing the normal homeostatic recovery mechanisms that would otherwise clear that debt.

In a person without insomnia, increasing sleep debt increases adenosine (sleep pressure), which drives faster sleep onset and deeper sleep — a self-correcting system. In a person with insomnia, the hyperarousal that maintains insomnia partly overrides this homeostatic drive, preventing the sleep pressure from converting efficiently into restorative sleep.

The result is a person who is genuinely sleep-deprived — who needs more sleep — but whose insomnia prevents the body from taking the sleep that would correct the debt. Standard sleep debt management advice ("just go to bed earlier") often backfires in insomnia because spending more time in bed without sleeping worsens the negative associations between bed and wakefulness, perpetuating the insomnia.

This is why insomnia treatment paradoxically begins with less time in bed — a technique called sleep restriction — before gradually extending it. The restriction temporarily intensifies sleep pressure to the point where it overrides the hyperarousal, re-establishing the brain's ability to fall asleep and stay asleep at appropriate times.

If you have significant sleep debt alongside insomnia symptoms, assess both: use the Sleep Debt Calculator for your debt level and the Insomnia Self-Assessment for your insomnia severity. Addressing both simultaneously — with CBT-I for the insomnia and eventually gradual sleep extension once the insomnia is under control — is more effective than addressing either alone.

Treatment: CBT-I Is the First-Line Recommendation

The evidence for treatment of insomnia disorder is unambiguous: Cognitive Behavioural Therapy for Insomnia (CBT-I) is the recommended first-line treatment — ahead of any pharmacological option — according to the American Academy of Sleep Medicine, the American College of Physicians, and European sleep medicine societies.

A 2025 systematic review published in Behavioural and Cognitive Psychotherapy (32 studies, 5,231 participants) confirmed that CBT-I in routine clinical care produces large effects on insomnia severity, consistent with efficacy results from controlled trials. A 2025 meta-analysis in npj Digital Medicine confirmed that fully automated digital CBT-I (without therapist guidance) also produces moderate-to-large effects on insomnia severity — making effective treatment more accessible than ever.

What CBT-I consists of

CBT-I is a structured, multi-component treatment typically delivered across four to eight sessions. Its components — confirmed effective in a 2024 comprehensive network meta-analysis of 241 RCTs — include:

Sleep restriction therapy (most evidence-supported component): Temporarily restricts time in bed to match actual sleep time (e.g., if you sleep five hours, you are allowed only five hours in bed). This intensifies sleep pressure rapidly, re-establishes the ability to fall asleep quickly and sleep through the night, and then time in bed is gradually extended as sleep efficiency improves. It is counterintuitive and temporarily uncomfortable — but produces the fastest, most durable results of any insomnia intervention.

Stimulus control (strong evidence): Re-associates the bed and bedroom exclusively with sleep and sex by: getting out of bed if unable to sleep within 20 minutes, avoiding all non-sleep activities in bed (screens, reading, working), and maintaining a consistent wake time. Breaks the conditioned arousal response that perpetuates insomnia.

Cognitive restructuring (strong evidence): Identifies and challenges the dysfunctional beliefs about sleep that maintain insomnia — "I must get eight hours or tomorrow will be ruined," "I will never be able to sleep normally," "If I don't sleep I can't function." Replaces these with accurate, less arousing beliefs that reduce the sleep effort that paradoxically prevents sleep.

Sleep hygiene education (used in combination; limited standalone evidence): Addresses behavioural factors — caffeine timing, alcohol, exercise timing, light exposure — that affect sleep quality. The 2024 network meta-analysis found that sleep hygiene alone is not effective as a standalone insomnia treatment, but it remains an important component alongside the more active elements.

Relaxation techniques (moderate evidence): Progressive muscle relaxation, diaphragmatic breathing, mindfulness, and imagery-based techniques reduce physiological hyperarousal at bedtime and during nocturnal awakenings.

Digital CBT-I: evidence-based and accessible

The most significant recent development in insomnia treatment is the validation of fully automated digital CBT-I as an effective intervention. A 2025 randomised controlled trial published in JMIR Mental Health (Prather et al., SleepioRx — an FDA-cleared digital CBT-I program) found significant improvements in insomnia disorder compared to sleep hygiene education controls. The 2025 npj Digital Medicine systematic review confirmed moderate-to-large effects from automated digital CBT-I across multiple trials.

Digital CBT-I removes the primary access barrier — the need for a trained therapist — while delivering the core evidence-based components through guided, interactive programs. Apps including Sleepio (FDA-cleared), Somryst (FDA-cleared), and others provide validated digital CBT-I. The American Academy of Sleep Medicine published a 2024 position paper on digital CBT-I platforms and their appropriate use contexts.

What about sleeping pills?

Pharmacological treatment of insomnia — including benzodiazepines, Z-drugs (zolpidem, zopiclone, eszopiclone), and newer agents (suvorexant, lemborexant, daridorexant) — produces short-term improvements in sleep onset and maintenance. However:

Effects diminish with tolerance over weeks
Dependence risk is significant for benzodiazepines and Z-drugs
Rebound insomnia on discontinuation is common
Cognitive side effects (next-day sedation, memory impairment) are documented
None address the perpetuating factors that maintain chronic insomnia — meaning symptoms return when medication is stopped

The American College of Physicians clinical practice guideline explicitly recommends CBT-I as the first-line treatment and pharmacotherapy as a second-line option only when CBT-I has failed or is unavailable. For most people with chronic insomnia disorder, sleep medication manages symptoms without addressing the cause — while CBT-I addresses the cause and produces durable remission.

The ISI in Clinical Practice: Tracking Improvement

One of the most valuable uses of the ISI is not just initial assessment but ongoing tracking. Because it is standardised and sensitive to change, the ISI can document treatment response week by week — confirming that CBT-I or other interventions are working before the improvement is fully subjectively apparent.

A clinically meaningful response to CBT-I is typically defined as a reduction of six or more points on the ISI, and remission is defined as a score below 8. Most people completing a full CBT-I course show response within three to four weeks of starting sleep restriction, with remission typically achieved by session five to eight.

Track your ISI score using the Insomnia Self-Assessment tool every two weeks during treatment. A declining score confirms the intervention is working. A stable or rising score warrants reviewing compliance with sleep restriction and stimulus control, and potentially seeking therapist-guided CBT-I if self-guided approaches have stalled.

Frequently Asked Questions

What is an insomnia self-assessment?

An insomnia self-assessment is a validated questionnaire-based tool that measures insomnia symptom severity and helps determine whether your sleep difficulties meet clinical criteria for insomnia disorder. The most widely validated tool is the Insomnia Severity Index (ISI) — a seven-question scale where scores of 8 or above indicate significant insomnia and scores of 15 or above indicate moderate-to-severe clinical insomnia warranting treatment. The Insomnia Self-Assessment tool provides a guided version with score interpretation.

How do I know if I have insomnia or just sleep debt?

Sleep debt and insomnia are distinct: sleep debt is a quantity problem (not enough hours), while insomnia is a process problem (difficulty initiating or maintaining sleep despite adequate opportunity). A person with sleep debt typically falls asleep easily and would sleep longer if allowed; a person with insomnia wants to sleep but cannot, despite having enough time in bed. Key indicator: if you lie awake for 30 or more minutes before falling asleep, or wake for 30 or more minutes during the night, on three or more nights per week, for three or more months — that profile suggests insomnia. Use both the Insomnia Self-Assessment and the Sleep Debt Calculator to assess both.

Is CBT-I really more effective than sleeping pills?

Yes — for long-term outcomes, consistently and substantially. CBT-I produces durable remission because it addresses the perpetuating factors that maintain chronic insomnia. Sleeping pills produce short-term symptomatic relief without addressing the cause — meaning symptoms return when medication is stopped. The American College of Physicians, the American Academy of Sleep Medicine, and major European sleep medicine organisations all recommend CBT-I as first-line treatment ahead of pharmacotherapy. A 2025 Behavioural and Cognitive Psychotherapy systematic review of 32 studies confirmed large effects of CBT-I in routine clinical care.

How long does it take for CBT-I to work?

Most people experience meaningful improvement within three to four weeks of starting CBT-I, particularly with the sleep restriction component. Full remission — an ISI score below 8 — is typically achieved within four to eight weeks of a complete CBT-I program. The initial weeks of sleep restriction can feel worse before improving (temporarily increasing daytime sleepiness as sleep pressure builds), which is normal and expected. Improvement is typically measurable on ISI scores by week two or three even when subjective sleep still feels difficult.

Can insomnia go away on its own?

Acute insomnia — triggered by a specific stressful event — often resolves within a few weeks when the trigger resolves, provided that maladaptive coping behaviours (excessive time in bed, compensatory napping, alcohol) are not adopted. Chronic insomnia (three months or more) rarely resolves without intervention, because the perpetuating factors that maintain it operate independently of the original precipitating cause. Research shows insomnia is more likely to persist or worsen over time without treatment than to spontaneously remit at clinical severity levels.

What is the difference between insomnia disorder and poor sleep?

Poor sleep is a broad umbrella term covering insufficient sleep duration (sleep debt), poor sleep quality (fragmented or non-restorative sleep from any cause), or sleep at the wrong time (circadian misalignment). Insomnia disorder is a clinically specific condition: difficulty initiating or maintaining sleep despite adequate opportunity, on at least three nights per week for at least three months, with significant daytime impairment. Not all poor sleepers have insomnia disorder, and addressing poor sleep hygiene — the first approach for general poor sleep — is not sufficient for clinical insomnia disorder, which requires CBT-I.

Should I see a doctor for insomnia?

If your ISI score is 15 or above (moderate-to-severe insomnia), you should discuss your symptoms with your physician. They can rule out medical causes (sleep apnea, restless leg syndrome, thyroid disorders, pain), review medications that may be contributing, and refer you to a sleep specialist or CBT-I program. If your score is 8–14 (subclinical to moderate), a self-guided or digital CBT-I program is an appropriate starting point. If you are using sleeping pills regularly, discuss with your doctor before discontinuing — abrupt cessation of benzodiazepines carries rebound risk.

The Bottom Line

Insomnia disorder affects approximately 12–16% of adults by clinical criteria — making it far more common than most people realise and far more specific than the casual use of the word "insomnia" suggests. An insomnia self-assessment using the ISI gives you a precise, validated score that distinguishes clinical insomnia from poor sleep hygiene, sleep debt, and other sleep disorders.

The most important insight: insomnia disorder does not respond well to the approaches that work for sleep debt. Going to bed earlier, sleeping longer on weekends, improving sleep hygiene — these help with sleep debt but can worsen insomnia by increasing time in bed and reinforcing the negative associations that perpetuate the disorder. The correct treatment for clinical insomnia is CBT-I — a structured, evidence-based program with large, durable effects, endorsed as first-line treatment by every major sleep medicine authority.

Start with your score. Use the Insomnia Self-Assessment tool now. If your score is 8 or above, read about CBT-I programs and consider discussing your symptoms with your physician. If you also want to understand your broader sleep deficit, use the Sleep Debt Calculator alongside.

Tools Referenced in This Article

Insomnia Self-Assessment — Score your insomnia symptoms with the ISI
Sleep Debt Calculator — Assess your cumulative sleep deficit alongside insomnia
Sleep Apnea Risk Screener — Rule out OSA as a cause of sleep maintenance insomnia
Sleep Quality Score — Track treatment progress week by week
Sleep Hygiene Checklist — Address perpetuating behavioural factors
Weekly Sleep Planner — Implement consistent sleep scheduling

References

van Straten A, et al. The prevalence of insomnia disorder in the general population: a meta-analysis. Journal of Sleep Research. 2025;34(5):e70089. doi:10.1111/jsr.70089. https://onlinelibrary.wiley.com/doi/10.1111/jsr.70089
Morin CM, et al. Insomnia Severity Index (ISI): psychometric properties. The societal and economic burden of insomnia in adults. RAND Corporation. https://www.rand.org/content/dam/rand/pubs/research_reports/RRA2100/RRA2166-1/RAND_RRA2166-1.pdf
Prevalence, subtypes, and comorbidity of DSM-5 insomnia disorder among adults in Beijing, China. BMC Public Health. 2026. doi:10.1186/s12889-026-26453-x. https://link.springer.com/article/10.1186/s12889-026-26453-x
Riemann D, et al. Cognitive behavioural therapy for insomnia in routine clinical care: a systematic review and meta-analysis. Behavioural and Cognitive Psychotherapy. 2025. doi:10.1080/16506073.2025.2588173. https://www.tandfonline.com/doi/full/10.1080/16506073.2025.2588173
Liang X, et al. Systematic review and meta-analysis on fully automated digital CBT for insomnia. npj Digital Medicine. 2025. doi:10.1038/s41746-025-01514-4. https://www.nature.com/articles/s41746-025-01514-4
Prather AA, Krystal AD, et al. The effectiveness of digital CBT-I to treat insomnia disorder in US adults: nationwide decentralised RCT. JMIR Mental Health. 2025;12:e84323. doi:10.2196/84323. https://mental.jmir.org/2025/1/e84323
Frontiers in Psychiatry. Effectiveness of unguided digital CBT-I on depressive symptoms: a systematic review and meta-analysis of RCTs. 2025. doi:10.3389/fpsyt.2025.1718949. https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2025.1718949/full
Cognitive behavioral therapy for insomnia to treat major depressive disorder with comorbid insomnia: a systematic review and meta-analysis. ScienceDirect / Journal of Affective Disorders. 2024. doi:10.1016/j.jad.2024.07.025. https://www.sciencedirect.com/science/article/pii/S0165032724014952
ResmedSleepInstitute. How CBT-I revolutionizes insomnia treatment. October 2025. https://www.resmedsleepinstitute.com/trends-innovation/how-cbt-i-revolutionizes-insomnia-treatment
Edinger J, Arnedt T, et al. Behavioral and psychological treatments for chronic insomnia disorder in adults: AASM systematic review, meta-analysis, and GRADE assessment. Journal of Clinical Sleep Medicine. 2021;17(2). https://jcsm.aasm.org/doi/10.5664/jcsm.8988
International study of the prevalence and factors associated with insomnia in the general population. ScienceDirect / Sleep Medicine. 2021. doi:10.1016/j.sleep.2021.01.011. https://www.sciencedirect.com/science/article/abs/pii/S1389945721001994
Structural validity of the ISI: a systematic review and meta-analysis. ScienceDirect / Sleep Medicine Reviews. 2021. doi:10.1016/j.smrv.2021.101509. https://www.sciencedirect.com/science/article/abs/pii/S1087079221001167
American Academy of Sleep Medicine. Digital cognitive behavioral therapy for insomnia: platforms and characteristics. March 2024. https://aasm.org/clinical-resources/clinical-guidelines/
National Sleep Foundation. Insomnia. sleepfoundation.org. Accessed May 2026. https://www.sleepfoundation.org/insomnia

Disclaimer: This article is for educational and informational purposes only and does not constitute medical advice. The Insomnia Severity Index and self-assessment tools are screening instruments, not diagnostic tests. If you are experiencing persistent sleep problems or your ISI score is 15 or above, please consult a qualified healthcare professional or a board-certified sleep medicine specialist.